Skip to main content

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

VIR holding history

Vir Biotechnology, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VIR overviewAll 13F holders of VIRFull Q2 2026 holdings

Shares (Q2 2026)
71
Value
$723
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VIR by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202671$723<0.1%00.0%UnchangedHolders
Q1 202671$636<0.1%+71NewHolders
Q4 20250$00.0%−468−100.0%Sold outHolders
Q3 2025468$2.67K<0.1%00.0%UnchangedHolders
Q2 2025468$2.36K<0.1%−44−8.6%ReducedHolders
Q1 2025512$3.32K<0.1%00.0%UnchangedHolders
Q4 2024512$3.76K<0.1%00.0%UnchangedHolders
Q3 2024512$3.83K<0.1%−265−34.1%ReducedHolders
Q2 2024777$6.92K<0.1%−74−8.7%ReducedHolders
Q1 2024851$8.62K<0.1%00.0%UnchangedHolders
Q4 2023851$8.56K<0.1%+352+70.5%AddedHolders
Q3 2023499$4.68K<0.1%−5−1.0%ReducedHolders
Q2 2023504$12.4K<0.1%−73−12.7%ReducedHolders
Q1 2023577$13.4K<0.1%+567+5,670.0%AddedHolders
Q4 202210$253<0.1%−7−41.2%ReducedHolders
Q3 202217$00.0%−6−26.1%ReducedHolders
Q2 202223$1.00K<0.1%+13+130.0%AddedHolders
Q1 202210$00.0%−44−81.5%ReducedHolders
Q4 202154$2.00K<0.1%−20,725−99.7%ReducedHolders
Q3 202120,779$904.0K<0.1%−10,383−33.3%ReducedHolders
Q2 202131,162$1.47M0.1%+22,364+254.2%AddedHolders
Q1 20218,798$451.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.